Advisory Commission on Childhood Vaccines; Notice of Meeting, 27797 [2010-11837]

Download as PDF Federal Register / Vol. 75, No. 95 / Tuesday, May 18, 2010 / Notices onto the NIH campus. All visitor vehicles, including taxis, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: http://www. nichd.nih.gov/about/nachhd.htm, where an agenda and any additional information for the meeting will be posted when available. In order to facilitate public attendance at the open session of Council, reserve seating will be made available to the first five individuals reserving seats in the main meeting room, Conference Room 6. Please contact Ms. Lisa Kaeser, Program and Public Liaison Office, NICHD, at 301–496–0536 to make your reservation. Additional seating will be available in the meeting overflow rooms, Conference Rooms 7 and 8. Individuals will also be able to view the meeting via NIH Videocast. Please go to the following link for Videocast access instructions at: http://wwwauthor.nichd.nih. gov/about/overview/advisory/nachhd/virtualmeeting-201005.cfm. The meeting is partially closed to the public. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment program, National Institutes of Health, HHS) Dated: May 12, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. Password: ACCV. Agenda: The agenda items for the December meeting will include, but are not limited to: updates from the Division of Vaccine Injury Compensation (DVIC), Department of Justice, National Vaccine Program Office, Immunization Safety Office (Centers for Disease Control and Prevention), National Institute of Allergy and Infectious Diseases (National Institutes of Health), and Center for Biologics, Evaluation and Research (Food and Drug Administration). Agenda items are subject to change as priorities dictate. Public Comments: Persons interested in providing an oral presentation should submit a written request, along with a copy of their presentation to: Annie Herzog, DVIC, Healthcare Systems Bureau (HSB), Health Resources and Services Administration (HRSA), Room 11C–26, 5600 Fishers Lane, Rockville, Maryland 20857 or e-mail: aherzog@hrsa.gov. Requests should contain the name, address, telephone number, and any business or professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. DVIC will notify each presenter by mail or telephone of their assigned presentation time. Persons who do not file an advance request for a presentation, but desire to make an oral statement, may announce it at the time of the comment period. These persons will be allocated time as it permits. FOR FURTHER INFORMATION CONTACT: Anyone requiring information regarding the ACCV should contact Annie Herzog, DVIC, HSB, HRSA, Room 11C–26, 5600 Fishers Lane, Rockville, MD 20857; telephone (301) 443–6593 or e-mail: aherzog@hrsa.gov. [FR Doc. 2010–11848 Filed 5–17–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: May 11, 2010. Sahira Rafiullah, Director, Division of Policy and Information Coordination. Health Resources and Services Administration [FR Doc. 2010–11837 Filed 5–17–10; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Times and Date: 11:30 a.m.–6:30 p.m., June 17, 2010 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5, U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Section 10(d) of Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Prevention of Suicidal Behavior through the Enhancement of Connectedness (U01), RFA CE10–006’’. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Jane Suen, Dr.P.H., M.S., National Center for Injury Prevention and Control, Office of the Director, Extramural Research Program Office, 4770 Buford Highway, NE., Mailstop F– 63, Atlanta, Georgia 30341, Telephone (770) 488–4281. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: May 11, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–11887 Filed 5–17–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4165–15–P In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: mstockstill on DSKH9S0YB1PROD with NOTICES Advisory Commission on Childhood Vaccines; Notice of Meeting 27797 Name: Advisory Commission on Childhood Vaccines (ACCV). Date and Time: June 10, 2010, 1 p.m. to 5:30 p.m. EDT; June 11, 2010, 9 a.m. to 12:30 p.m. EDT. Place: Parklawn Building (and via audio conference call), Conference Rooms G & H, 5600 Fishers Lane, Rockville, MD 20857. The ACCV will meet on Thursday, June 10 from 1 pm to 5:30 pm (EDT) and Friday, June 11 from 9 a.m. to 12:30 p.m. (EDT). The public can join the meeting via audio conference call by dialing 1–888–849–8919 on June 10 & 11 and providing the following information: Leader’s Name: Dr. Geoffrey Evans. VerDate Mar<15>2010 17:22 May 17, 2010 Jkt 220001 Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Prevention of Suicidal Behavior through the Enhancement of Connectedness (U01), Request for Applications (RFA) CE10–006, initial review. In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the aforementioned meeting: PO 00000 Frm 00097 Fmt 4703 Sfmt 4703 Notice of Meeting Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Evaluation of Offering and Documenting Influenza Vaccination for Nursing Home Residents, Funding Opportunity Announcement (FOA) IP10–001; Development, Implementation, and Evaluation of a Multi-Component Intervention to Vaccinate Adolescents at Risk for Vaccine-Preventable Diseases, FOA IP10–002; Evaluation and Impact of a State Law Requiring Mandatory Influenza Vaccination of Hospital Employees, FOA IP10–003; and Improving the Translation of the E:\FR\FM\18MYN1.SGM 18MYN1

Agencies

[Federal Register Volume 75, Number 95 (Tuesday, May 18, 2010)]
[Notices]
[Page 27797]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-11837]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission on Childhood Vaccines; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:

    Name: Advisory Commission on Childhood Vaccines (ACCV).
    Date and Time: June 10, 2010, 1 p.m. to 5:30 p.m. EDT; June 11, 
2010, 9 a.m. to 12:30 p.m. EDT.
    Place: Parklawn Building (and via audio conference call), 
Conference Rooms G & H, 5600 Fishers Lane, Rockville, MD 20857.
    The ACCV will meet on Thursday, June 10 from 1 pm to 5:30 pm 
(EDT) and Friday, June 11 from 9 a.m. to 12:30 p.m. (EDT). The 
public can join the meeting via audio conference call by dialing 1-
888-849-8919 on June 10 & 11 and providing the following 
information:
    Leader's Name: Dr. Geoffrey Evans.
    Password: ACCV.
    Agenda: The agenda items for the December meeting will include, 
but are not limited to: updates from the Division of Vaccine Injury 
Compensation (DVIC), Department of Justice, National Vaccine Program 
Office, Immunization Safety Office (Centers for Disease Control and 
Prevention), National Institute of Allergy and Infectious Diseases 
(National Institutes of Health), and Center for Biologics, 
Evaluation and Research (Food and Drug Administration). Agenda items 
are subject to change as priorities dictate.
    Public Comments: Persons interested in providing an oral 
presentation should submit a written request, along with a copy of 
their presentation to: Annie Herzog, DVIC, Healthcare Systems Bureau 
(HSB), Health Resources and Services Administration (HRSA), Room 
11C-26, 5600 Fishers Lane, Rockville, Maryland 20857 or e-mail: 
aherzog@hrsa.gov. Requests should contain the name, address, 
telephone number, and any business or professional affiliation of 
the person desiring to make an oral presentation. Groups having 
similar interests are requested to combine their comments and 
present them through a single representative. The allocation of time 
may be adjusted to accommodate the level of expressed interest. DVIC 
will notify each presenter by mail or telephone of their assigned 
presentation time. Persons who do not file an advance request for a 
presentation, but desire to make an oral statement, may announce it 
at the time of the comment period. These persons will be allocated 
time as it permits.

FOR FURTHER INFORMATION CONTACT: Anyone requiring information regarding 
the ACCV should contact Annie Herzog, DVIC, HSB, HRSA, Room 11C-26, 
5600 Fishers Lane, Rockville, MD 20857; telephone (301) 443-6593 or e-
mail: aherzog@hrsa.gov.

    Dated: May 11, 2010.
Sahira Rafiullah,
Director, Division of Policy and Information Coordination.
[FR Doc. 2010-11837 Filed 5-17-10; 8:45 am]
BILLING CODE 4165-15-P